Cargando…
P1225: SECONDARY PRIMARY MALIGNANCIES (SPM) AFTER HIGH-DOSE CHEMOTHERAPY (HDT) WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDY
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430672/ http://dx.doi.org/10.1097/01.HS9.0000847764.17058.3f |
| _version_ | 1784779839113265152 |
|---|---|
| author | Trab, T. Baech, J. Hjort Jakobsen, L. Husby, S. Tang Severinsen, M. Eloranta, S. Gørløv, J. S. Jørgensen, J. M. Gudbrandsdottir, S. Stauffer Larsen, T. Brown, P. Smedby, K. E. Christoffer El-Galaly, T. |
| author_facet | Trab, T. Baech, J. Hjort Jakobsen, L. Husby, S. Tang Severinsen, M. Eloranta, S. Gørløv, J. S. Jørgensen, J. M. Gudbrandsdottir, S. Stauffer Larsen, T. Brown, P. Smedby, K. E. Christoffer El-Galaly, T. |
| author_sort | Trab, T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430672 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94306722022-08-31 P1225: SECONDARY PRIMARY MALIGNANCIES (SPM) AFTER HIGH-DOSE CHEMOTHERAPY (HDT) WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDY Trab, T. Baech, J. Hjort Jakobsen, L. Husby, S. Tang Severinsen, M. Eloranta, S. Gørløv, J. S. Jørgensen, J. M. Gudbrandsdottir, S. Stauffer Larsen, T. Brown, P. Smedby, K. E. Christoffer El-Galaly, T. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430672/ http://dx.doi.org/10.1097/01.HS9.0000847764.17058.3f Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Trab, T. Baech, J. Hjort Jakobsen, L. Husby, S. Tang Severinsen, M. Eloranta, S. Gørløv, J. S. Jørgensen, J. M. Gudbrandsdottir, S. Stauffer Larsen, T. Brown, P. Smedby, K. E. Christoffer El-Galaly, T. P1225: SECONDARY PRIMARY MALIGNANCIES (SPM) AFTER HIGH-DOSE CHEMOTHERAPY (HDT) WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDY |
| title | P1225: SECONDARY PRIMARY MALIGNANCIES (SPM) AFTER HIGH-DOSE CHEMOTHERAPY (HDT) WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDY |
| title_full | P1225: SECONDARY PRIMARY MALIGNANCIES (SPM) AFTER HIGH-DOSE CHEMOTHERAPY (HDT) WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDY |
| title_fullStr | P1225: SECONDARY PRIMARY MALIGNANCIES (SPM) AFTER HIGH-DOSE CHEMOTHERAPY (HDT) WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDY |
| title_full_unstemmed | P1225: SECONDARY PRIMARY MALIGNANCIES (SPM) AFTER HIGH-DOSE CHEMOTHERAPY (HDT) WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDY |
| title_short | P1225: SECONDARY PRIMARY MALIGNANCIES (SPM) AFTER HIGH-DOSE CHEMOTHERAPY (HDT) WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDY |
| title_sort | p1225: secondary primary malignancies (spm) after high-dose chemotherapy (hdt) with autologous stem cell transplant (asct) for lymphoma: a danish nationwide cohort study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430672/ http://dx.doi.org/10.1097/01.HS9.0000847764.17058.3f |
| work_keys_str_mv | AT trabt p1225secondaryprimarymalignanciesspmafterhighdosechemotherapyhdtwithautologousstemcelltransplantasctforlymphomaadanishnationwidecohortstudy AT baechj p1225secondaryprimarymalignanciesspmafterhighdosechemotherapyhdtwithautologousstemcelltransplantasctforlymphomaadanishnationwidecohortstudy AT hjortjakobsenl p1225secondaryprimarymalignanciesspmafterhighdosechemotherapyhdtwithautologousstemcelltransplantasctforlymphomaadanishnationwidecohortstudy AT husbys p1225secondaryprimarymalignanciesspmafterhighdosechemotherapyhdtwithautologousstemcelltransplantasctforlymphomaadanishnationwidecohortstudy AT tangseverinsenm p1225secondaryprimarymalignanciesspmafterhighdosechemotherapyhdtwithautologousstemcelltransplantasctforlymphomaadanishnationwidecohortstudy AT elorantas p1225secondaryprimarymalignanciesspmafterhighdosechemotherapyhdtwithautologousstemcelltransplantasctforlymphomaadanishnationwidecohortstudy AT gørløvjs p1225secondaryprimarymalignanciesspmafterhighdosechemotherapyhdtwithautologousstemcelltransplantasctforlymphomaadanishnationwidecohortstudy AT jørgensenjm p1225secondaryprimarymalignanciesspmafterhighdosechemotherapyhdtwithautologousstemcelltransplantasctforlymphomaadanishnationwidecohortstudy AT gudbrandsdottirs p1225secondaryprimarymalignanciesspmafterhighdosechemotherapyhdtwithautologousstemcelltransplantasctforlymphomaadanishnationwidecohortstudy AT staufferlarsent p1225secondaryprimarymalignanciesspmafterhighdosechemotherapyhdtwithautologousstemcelltransplantasctforlymphomaadanishnationwidecohortstudy AT brownp p1225secondaryprimarymalignanciesspmafterhighdosechemotherapyhdtwithautologousstemcelltransplantasctforlymphomaadanishnationwidecohortstudy AT smedbyke p1225secondaryprimarymalignanciesspmafterhighdosechemotherapyhdtwithautologousstemcelltransplantasctforlymphomaadanishnationwidecohortstudy AT christofferelgalalyt p1225secondaryprimarymalignanciesspmafterhighdosechemotherapyhdtwithautologousstemcelltransplantasctforlymphomaadanishnationwidecohortstudy |